Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Michel and Claire Revel are an Israeli angel group that has invested in biotechnology companies.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is the primary sector focus for Michel and Claire Revel's investments?
- Michel and Claire Revel primarily focus on the Health Tech & Life Sciences sector, with their sole recorded investment in this area.
- When did Michel and Claire Revel make their most recent investment?
- Michel and Claire Revel made their most recent investment in October 2018.
- Can you name a notable company in Michel and Claire Revel's portfolio?
- NewCelX, a company focused on cell therapies for neurodegenerative and metabolic diseases, is a notable company in Michel and Claire Revel's portfolio.
- What is the typical investment stage for Michel and Claire Revel?
- Michel and Claire Revel have participated in PIPE rounds, indicating an investment focus on later-stage companies.
- What is the investment range for Michel and Claire Revel?
- Michel and Claire Revel's investment range is between $5.15M and $5.15M.